Clinuvel Pharmaceuticals LimitedASX: CUV

Encouraging interim safety results in Phase II OTR study

Feb 10, 2016 at 8:19 PM EST · Issued by Clinuvel Pharmaceuticals Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

6ix hasn’t read this filing yet.

Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.